All-cause mortality in young women with endometrial cancer receiving progesterone therapy
Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy.
Gespeichert in:
| Autor*in: |
Ruiz, Maria P. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
60223 |
|---|
| Übergeordnetes Werk: |
Enthalten in: IS - Domingues, Sara ELSEVIER, 2018, AJOG, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:217 ; year:2017 ; number:6 ; pages:6691-66913 ; extent:60223 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajog.2017.08.007 |
|---|
| Katalog-ID: |
ELV041254600 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV041254600 | ||
| 003 | DE-627 | ||
| 005 | 20230624083628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajog.2017.08.007 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000406.pica |
| 035 | |a (DE-627)ELV041254600 | ||
| 035 | |a (ELSEVIER)S0002-9378(17)30942-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Ruiz, Maria P. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a All-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| 264 | 1 | |c 2017 | |
| 300 | |a 60223 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. | ||
| 650 | 7 | |a uterine cancer |2 Elsevier | |
| 650 | 7 | |a progesterone |2 Elsevier | |
| 650 | 7 | |a endometrial cancer |2 Elsevier | |
| 700 | 1 | |a Huang, Yongmei |4 oth | |
| 700 | 1 | |a Hou, June Y. |4 oth | |
| 700 | 1 | |a Tergas, Ana I. |4 oth | |
| 700 | 1 | |a Burke, William M. |4 oth | |
| 700 | 1 | |a Ananth, Cande V. |4 oth | |
| 700 | 1 | |a Neugut, Alfred I. |4 oth | |
| 700 | 1 | |a Hershman, Dawn L. |4 oth | |
| 700 | 1 | |a Wright, Jason D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Domingues, Sara ELSEVIER |t IS |d 2018 |d AJOG |g Orlando, Fla |w (DE-627)ELV000288284 |
| 773 | 1 | 8 | |g volume:217 |g year:2017 |g number:6 |g pages:6691-66913 |g extent:60223 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajog.2017.08.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 217 |j 2017 |e 6 |h 6691-66913 |g 60223 |y 217.2017, 6, 669.e1-, (60223 S.) | ||
| author_variant |
m p r mp mpr |
|---|---|
| matchkey_str |
ruizmariaphuangyongmeihoujuneytergasanai:2017----:lcueotltiyugoewtedmtilacreev |
| hierarchy_sort_str |
2017 |
| publishDate |
2017 |
| allfields |
10.1016/j.ajog.2017.08.007 doi GBV00000000000406.pica (DE-627)ELV041254600 (ELSEVIER)S0002-9378(17)30942-0 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Ruiz, Maria P. verfasserin aut All-cause mortality in young women with endometrial cancer receiving progesterone therapy 2017 60223 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. uterine cancer Elsevier progesterone Elsevier endometrial cancer Elsevier Huang, Yongmei oth Hou, June Y. oth Tergas, Ana I. oth Burke, William M. oth Ananth, Cande V. oth Neugut, Alfred I. oth Hershman, Dawn L. oth Wright, Jason D. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:217 year:2017 number:6 pages:6691-66913 extent:60223 https://doi.org/10.1016/j.ajog.2017.08.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 217 2017 6 6691-66913 60223 217.2017, 6, 669.e1-, (60223 S.) |
| spelling |
10.1016/j.ajog.2017.08.007 doi GBV00000000000406.pica (DE-627)ELV041254600 (ELSEVIER)S0002-9378(17)30942-0 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Ruiz, Maria P. verfasserin aut All-cause mortality in young women with endometrial cancer receiving progesterone therapy 2017 60223 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. uterine cancer Elsevier progesterone Elsevier endometrial cancer Elsevier Huang, Yongmei oth Hou, June Y. oth Tergas, Ana I. oth Burke, William M. oth Ananth, Cande V. oth Neugut, Alfred I. oth Hershman, Dawn L. oth Wright, Jason D. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:217 year:2017 number:6 pages:6691-66913 extent:60223 https://doi.org/10.1016/j.ajog.2017.08.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 217 2017 6 6691-66913 60223 217.2017, 6, 669.e1-, (60223 S.) |
| allfields_unstemmed |
10.1016/j.ajog.2017.08.007 doi GBV00000000000406.pica (DE-627)ELV041254600 (ELSEVIER)S0002-9378(17)30942-0 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Ruiz, Maria P. verfasserin aut All-cause mortality in young women with endometrial cancer receiving progesterone therapy 2017 60223 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. uterine cancer Elsevier progesterone Elsevier endometrial cancer Elsevier Huang, Yongmei oth Hou, June Y. oth Tergas, Ana I. oth Burke, William M. oth Ananth, Cande V. oth Neugut, Alfred I. oth Hershman, Dawn L. oth Wright, Jason D. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:217 year:2017 number:6 pages:6691-66913 extent:60223 https://doi.org/10.1016/j.ajog.2017.08.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 217 2017 6 6691-66913 60223 217.2017, 6, 669.e1-, (60223 S.) |
| allfieldsGer |
10.1016/j.ajog.2017.08.007 doi GBV00000000000406.pica (DE-627)ELV041254600 (ELSEVIER)S0002-9378(17)30942-0 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Ruiz, Maria P. verfasserin aut All-cause mortality in young women with endometrial cancer receiving progesterone therapy 2017 60223 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. uterine cancer Elsevier progesterone Elsevier endometrial cancer Elsevier Huang, Yongmei oth Hou, June Y. oth Tergas, Ana I. oth Burke, William M. oth Ananth, Cande V. oth Neugut, Alfred I. oth Hershman, Dawn L. oth Wright, Jason D. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:217 year:2017 number:6 pages:6691-66913 extent:60223 https://doi.org/10.1016/j.ajog.2017.08.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 217 2017 6 6691-66913 60223 217.2017, 6, 669.e1-, (60223 S.) |
| allfieldsSound |
10.1016/j.ajog.2017.08.007 doi GBV00000000000406.pica (DE-627)ELV041254600 (ELSEVIER)S0002-9378(17)30942-0 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Ruiz, Maria P. verfasserin aut All-cause mortality in young women with endometrial cancer receiving progesterone therapy 2017 60223 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. uterine cancer Elsevier progesterone Elsevier endometrial cancer Elsevier Huang, Yongmei oth Hou, June Y. oth Tergas, Ana I. oth Burke, William M. oth Ananth, Cande V. oth Neugut, Alfred I. oth Hershman, Dawn L. oth Wright, Jason D. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:217 year:2017 number:6 pages:6691-66913 extent:60223 https://doi.org/10.1016/j.ajog.2017.08.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 217 2017 6 6691-66913 60223 217.2017, 6, 669.e1-, (60223 S.) |
| language |
English |
| source |
Enthalten in IS Orlando, Fla volume:217 year:2017 number:6 pages:6691-66913 extent:60223 |
| sourceStr |
Enthalten in IS Orlando, Fla volume:217 year:2017 number:6 pages:6691-66913 extent:60223 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
uterine cancer progesterone endometrial cancer |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
IS |
| authorswithroles_txt_mv |
Ruiz, Maria P. @@aut@@ Huang, Yongmei @@oth@@ Hou, June Y. @@oth@@ Tergas, Ana I. @@oth@@ Burke, William M. @@oth@@ Ananth, Cande V. @@oth@@ Neugut, Alfred I. @@oth@@ Hershman, Dawn L. @@oth@@ Wright, Jason D. @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000288284 |
| dewey-sort |
3570 |
| id |
ELV041254600 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041254600</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624083628.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2017.08.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000406.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041254600</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(17)30942-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ruiz, Maria P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">All-cause mortality in young women with endometrial cancer receiving progesterone therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">60223</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">uterine cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">progesterone</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">endometrial cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Yongmei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hou, June Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tergas, Ana I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burke, William M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ananth, Cande V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neugut, Alfred I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hershman, Dawn L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wright, Jason D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:217</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:6691-66913</subfield><subfield code="g">extent:60223</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2017.08.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">217</subfield><subfield code="j">2017</subfield><subfield code="e">6</subfield><subfield code="h">6691-66913</subfield><subfield code="g">60223</subfield><subfield code="y">217.2017, 6, 669.e1-, (60223 S.)</subfield></datafield></record></collection>
|
| author |
Ruiz, Maria P. |
| spellingShingle |
Ruiz, Maria P. ddc 570 fid BIODIV Elsevier uterine cancer Elsevier progesterone Elsevier endometrial cancer All-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| authorStr |
Ruiz, Maria P. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000288284 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ BIODIV DE-30 fid All-cause mortality in young women with endometrial cancer receiving progesterone therapy uterine cancer Elsevier progesterone Elsevier endometrial cancer Elsevier |
| topic |
ddc 570 fid BIODIV Elsevier uterine cancer Elsevier progesterone Elsevier endometrial cancer |
| topic_unstemmed |
ddc 570 fid BIODIV Elsevier uterine cancer Elsevier progesterone Elsevier endometrial cancer |
| topic_browse |
ddc 570 fid BIODIV Elsevier uterine cancer Elsevier progesterone Elsevier endometrial cancer |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y h yh j y h jy jyh a i t ai ait w m b wm wmb c v a cv cva a i n ai ain d l h dl dlh j d w jd jdw |
| hierarchy_parent_title |
IS |
| hierarchy_parent_id |
ELV000288284 |
| dewey-tens |
570 - Life sciences; biology |
| hierarchy_top_title |
IS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000288284 |
| title |
All-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| ctrlnum |
(DE-627)ELV041254600 (ELSEVIER)S0002-9378(17)30942-0 |
| title_full |
All-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| author_sort |
Ruiz, Maria P. |
| journal |
IS |
| journalStr |
IS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
6691 |
| author_browse |
Ruiz, Maria P. |
| container_volume |
217 |
| physical |
60223 |
| class |
570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ruiz, Maria P. |
| doi_str_mv |
10.1016/j.ajog.2017.08.007 |
| dewey-full |
570 |
| title_sort |
all-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| title_auth |
All-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| abstract |
Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. |
| abstractGer |
Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. |
| abstract_unstemmed |
Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
6 |
| title_short |
All-cause mortality in young women with endometrial cancer receiving progesterone therapy |
| url |
https://doi.org/10.1016/j.ajog.2017.08.007 |
| remote_bool |
true |
| author2 |
Huang, Yongmei Hou, June Y. Tergas, Ana I. Burke, William M. Ananth, Cande V. Neugut, Alfred I. Hershman, Dawn L. Wright, Jason D. |
| author2Str |
Huang, Yongmei Hou, June Y. Tergas, Ana I. Burke, William M. Ananth, Cande V. Neugut, Alfred I. Hershman, Dawn L. Wright, Jason D. |
| ppnlink |
ELV000288284 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ajog.2017.08.007 |
| up_date |
2024-07-06T19:37:50.541Z |
| _version_ |
1803859704458248192 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041254600</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624083628.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2017.08.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000406.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041254600</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(17)30942-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ruiz, Maria P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">All-cause mortality in young women with endometrial cancer receiving progesterone therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">60223</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">uterine cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">progesterone</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">endometrial cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Yongmei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hou, June Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tergas, Ana I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burke, William M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ananth, Cande V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neugut, Alfred I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hershman, Dawn L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wright, Jason D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:217</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:6691-66913</subfield><subfield code="g">extent:60223</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2017.08.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">217</subfield><subfield code="j">2017</subfield><subfield code="e">6</subfield><subfield code="h">6691-66913</subfield><subfield code="g">60223</subfield><subfield code="y">217.2017, 6, 669.e1-, (60223 S.)</subfield></datafield></record></collection>
|
| score |
7.4006004 |